GRACELL BIOTECHNOLOGIES INC's ticker is GRCL and the CUSIP is 38406L103. A total of 33 filers reported holding GRACELL BIOTECHNOLOGIES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,809,131 | -22.1% | 9,308,726 | +3.0% | 0.57% | -8.8% |
| Q2 2023 | $34,418,496 | +94.8% | 9,033,726 | -4.9% | 0.62% | +79.8% |
| Q1 2023 | $17,665,860 | -2.6% | 9,497,774 | +20.5% | 0.35% | 0.0% |
| Q4 2022 | $18,135,201 | -28.6% | 7,884,870 | 0.0% | 0.35% | -26.3% |
| Q3 2022 | $25,389,000 | -41.5% | 7,884,870 | 0.0% | 0.47% | -40.1% |
| Q2 2022 | $43,367,000 | +136.0% | 7,884,870 | 0.0% | 0.79% | +163.8% |
| Q1 2022 | $18,372,000 | -61.4% | 7,884,870 | 0.0% | 0.30% | -51.3% |
| Q4 2021 | $47,625,000 | -56.5% | 7,884,870 | 0.0% | 0.61% | -49.1% |
| Q3 2021 | $109,363,000 | +6.7% | 7,884,870 | 0.0% | 1.20% | +15.9% |
| Q2 2021 | $102,503,000 | -15.6% | 7,884,870 | 0.0% | 1.04% | -8.6% |
| Q1 2021 | $121,427,000 | – | 7,884,870 | – | 1.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,153,206 | $5,864,963 | 1.15% |
| SPHERA FUNDS MANAGEMENT LTD. | 2,360,580 | $4,390,679 | 0.73% |
| Orbimed Advisors | 9,497,774 | $17,665,860 | 0.35% |
| Vivo Capital, LLC | 1,463,983 | $2,723,008 | 0.19% |
| Temasek Holdings (Private) Ltd | 9,901,940 | $18,417,608 | 0.11% |
| EcoR1 Capital, LLC | 798,948 | $1,486,043 | 0.05% |
| Brainard Capital Management LLC | 25,913 | $48,198 | 0.04% |
| Schonfeld Strategic Advisors LLC | 613,179 | $1,140,512 | 0.01% |
| FEDERATED HERMES, INC. | 1,298,578 | $2,415,355 | 0.01% |
| Cannell Capital | 14,299 | $26,596 | 0.01% |